EAALX
Price
$20.47
Change
-$0.49 (-2.34%)
Updated
Apr 3 closing price
Net Assets
898.43M
GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

EAALX vs GFACX

Header iconEAALX vs GFACX Comparison
Open Charts EAALX vs GFACXBanner chart's image
Eaton Vance Atlanta Capital Focused Gr A
Price$20.47
Change-$0.49 (-2.34%)
VolumeN/A
Net Assets898.43M
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
EAALX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EAALX vs. GFACX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EAALX is a Buy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. EAALX (898M). EAALX (0.00) and GFACX (0.00) have matching dividends . EAALX was incepted earlier than GFACX: EAALX (21 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than EAALX (1.01). GFACX is a more actively managed with annual turnover of: 25.00 vs. EAALX (14.00). GFACX has a lower initial minimum investment than EAALX: GFACX (250) vs EAALX (1000). EAALX annual gain was more profitable for investors over the last year : 1.60 vs. GFACX (-1.75). EAALX return over 5 years is better than : 103.50 vs. GFACX (59.73).
EAALXGFACXEAALX / GFACX
Total Expense Ratio1.011.3674%
Annual Report Gross Expense Ratio1.011.3674%
Fund Existence21 years24 years-
Gain YTD0.479-5.003-10%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets898M280B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year1.60-1.75-91%
Returns for 3 years17.820.632,822%
Returns for 5 years103.5059.73173%
Returns for 10 years39.3644.4689%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences